CN Patent

CN115515958B — 一种新型磺酰胺类menin-MLL相互作用抑制剂、其制备方法及医药用途

Assigned to Chengdu Easton Biopharmaceuticals Co Ltd · Expires 2023-09-29 · 3y expired

What this patent protects

提供式(Ⅰ)化合物、其药用盐及其制备方法和用途。该化合物在治疗疾病和病症中可用作药剂，所述疾病和病症包括癌症,由menin‑MLL相互作用介导的其它疾病。

USPTO Abstract

提供式(Ⅰ)化合物、其药用盐及其制备方法和用途。该化合物在治疗疾病和病症中可用作药剂，所述疾病和病症包括癌症,由menin‑MLL相互作用介导的其它疾病。

Drugs covered by this patent

Patent Metadata

Patent number
CN115515958B
Jurisdiction
CN
Classification
—
Expires
2023-09-29
Drug substance claim
No
Drug product claim
No
Assignee
Chengdu Easton Biopharmaceuticals Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.